Has Bennett Baquet, MD received payments from drug or device companies?

Yes. Drug and device makers reported $29,950 in general payments to Bennett Baquet, MD across 523 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bennett Baquet, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bennett Baquet, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bennett Baquet, MD

Endocrinology, Diabetes & Metabolism · Lafayette, LANPI 1073563631

Payments from drug & device makers

$29,950in general payments, 2019–2025

Across 523 payments — averaging $57.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Tandem Diabetes Care, Inc.$23K
Dexcom, Inc.$2K
Amgen$915
Medtronic$405
AstraZeneca$378
Novo Nordisk$339
plus $4K from 47 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Tandem Diabetes Care, Inc.	84	$22,538
Dexcom, Inc.	118	$1,831
Amgen(2 entities)	61	$915
Medtronic	9	$405
AstraZeneca(2 entities)	21	$378
Novo Nordisk	25	$339
Lilly USA, LLC	19	$309
Abbott	11	$239
Sanofi-aventis U.S. LLC	13	$220
Radius Health, Inc.	12	$220
Merck	15	$202
Corcept Therapeutics	13	$185
Aurinia Pharma U.S., Inc.	10	$182
UCB, Inc.	9	$167
Insulet Corporation	7	$143
Sequel Med Tech, LLC	4	$139
Xeris Pharmaceuticals, Inc.	7	$138
Boehringer Ingelheim	7	$114
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$106
BETA Bionics, Inc.	7	$99
Amarin Pharma, Inc.	5	$90
Mallinckrodt Hospital Products Inc.	5	$88
Ascendis Pharma Endocrinology Inc	4	$66
ANI Pharmaceuticals, Inc.	3	$62
Esperion Therapeutics, Inc.	4	$55
Johnson & Johnson(2 entities)	3	$45
Recordati_rare_diseases_inc.	3	$45
AbbVie	3	$44
IBSA Pharma Inc.	2	$42
Chiesi USA, Inc.	2	$39
Companion Medical, Inc.	2	$36
Kyowa Kirin, Inc.	2	$36
Clarus Therapeutics Inc.	3	$36
Shire North American Group Inc	2	$32
Acella Pharmaceuticals, LLC	2	$31
Roche Diabetes Care, Inc.	1	$28
Amneal Pharmaceuticals LLC	2	$26
Amryt Pharma Holdings Ltd	1	$25
Fresenius Kabi USA, LLC	1	$25
Organon	2	$25
BD	1	$23
Madrigal Pharmaceuticals	1	$19
Ipsen Biopharmaceuticals, Inc	1	$18
Neurocrine Biosciences, Inc.	1	$18
Zealand Pharma US, Inc.	1	$17
Cequr Corporation	1	$17
Ultragenyx Pharmaceutical Inc.	1	$16
Rhythm Pharmaceuticals, Inc.	1	$15
Sandoz	1	$15
Pfizer	1	$14
Medexus Pharma, Inc.	1	$14
Antares Pharma, Inc.	1	$14
Vivus LLC	1	$10

How this compares

$29,950 in reported general payments places this provider in the 80th percentile of 95 endocrinology, diabetes & metabolism providers in Louisiana.

See all endocrinology, diabetes & metabolism providers in Louisiana →

Medicare billing

Part B allowed, 2024

$703,543

Medicare patients

1,459

Services billed

25,557

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Lafayette

Justin FontenotLafayette$905K
Ghyass RizkLafayette$16K
Tuan Huy TranMetairie$2M
Harold MillerHammond$1.1M
Timothy GilbertBaton Rouge$985K
Vivian FonsecaNew Orleans$700K
Frank GreenwayBaton Rouge$669K
Abdul KhanHammond$587K
Ileana TandronSlidell$527K
Jonathan WiseMetairie$463K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →